Table 1 Demographics and intraoperative data of women undergoing local anaesthetic thermal balloon endometrial ablation (LA-Thermachoice) between 2001 and 2011, n = 253
Variable | Number (%) |
|---|---|
Age | |
Mean | 44 |
SD | 4.7 |
BMI, n = 240 | |
Mean | 30 |
SD | 6.8 |
Cycle phase, n = 247 | |
Proliferative | 93 (37 %) |
Secretary | 91 (37 %) |
Menstruating | 34 (14 %) |
Mid cycle | 15 (6 %) |
Amenorrhoea due to drugs | 14 (6 %) |
Clinical findings (USS or hysteroscopic), n = 249 | |
Normal | 191 (77 %) |
Intramural fibroid | 39 (15 %) |
Submucosal fibroid <3 cm | 5 (2 %) |
Polyp | 7 (3 %) |
Other | 7 (3 %) |
Uterine size, cm, n = 249 | |
<10 | 184 (74 %) |
≥10 | 43 (17 %) |
Not recorded | 22 (9 %) |
Mean size | 8.6 |
SD | 1.2 |
Volume of fluid, ml | |
Thermachoice, n = 51 | |
Mean | 24.1 |
SD | 13.3 |
Thermachoice III, n = 185 | |
Mean | 19.1 |
SD | 11.2 |
Intrauterine pressure, mm Hg | |
Thermachoice, n = 51 | |
Mean | 157 |
SD | 16 |
Thermachoice III, n = 188 | |
Mean | 179 |
SD | 16 |
Mean visual analogue pain (VAS) immediately after procedure, n = 234 | |
Mean | 5.5 |
SD | 2.7 |
Not severe (VAS ≤8) | 200 (81 %) |
Severe (VAS ≥9) | 34 (14 %) |